An 82-year-old man should not routinely have a prostate biopsy. The decision depends more on life expectancy and cancer aggressiveness than age alone. For most, the risks of the procedure and potential overtreatment outweigh the benefits.
Why most prostate cancers in older men are not dangerous
By age 80, many men have cancerous cells in the prostate, but most will never cause symptoms or shorten life. These cancers often grow so slowly that the man will die from other causes before the cancer becomes a problem. Finding them through screening doesn’t improve survival and can lead to unnecessary stress and treatment.
PSA levels can be misleading in older men
Prostate-specific antigen (PSA) naturally rises with age due to benign prostate enlargement. A level that might trigger concern in a younger man is often normal in an 82-year-old. A steadily rising PSA or a sudden spike may warrant closer attention, but a single elevated number usually does not.
Biopsy risks increase with age
Prostate biopsy is not a minor procedure. It involves inserting needles through the rectum to take tissue samples. In older men, this raises the risk of serious infection, bleeding, and urinary problems. Men on blood thinners face even higher risks. Hospitalization after biopsy is more common in men over 80.
Non-invasive tests can guide decisions
Before considering a biopsy, doctors can use multiparametric MRI (mpMRI) or advanced blood tests like the 4Kscore or PHI. These help estimate the chance of finding aggressive cancer. If imaging shows no suspicious areas, a biopsy can often be avoided safely.
Active surveillance is a safer approach
If a biopsy finds low-grade cancer, the best course is usually active surveillance. This means regular monitoring with PSA tests and occasional imaging, not immediate treatment. It avoids the side effects of surgery or radiation, such as incontinence or erectile dysfunction, while still catching any changes.
When a biopsy might be necessary
A biopsy may be appropriate if there are signs of aggressive disease—such as a rapidly rising PSA, a very high PSA level, or symptoms like pain or difficulty urinating. In these cases, the potential benefit of diagnosing a harmful cancer may justify the risks. The decision should be based on overall health, not age alone.